栀子苷和栀子苷元血浆蛋白结合率的HPLC 法测定

丁 越1, 张 彤1*, 陶建生1, 李梦艺2, 蔡贞贞1

主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA
中国医药工业杂志 ›› 2012, Vol. 43 ›› Issue (10) : 857-860.
药品分析与质控 Analysis & Quality Control

栀子苷和栀子苷元血浆蛋白结合率的HPLC 法测定

作者信息 +

Determination of Plasma Protein Binding Rates of Geniposide and Genipin by HPLC

Author information +
History +

摘要

建立了高效液相色谱法测定栀子苷和栀子苷元的血浆蛋白结合率。采用C18 色谱柱,流动相为乙腈-0.05%磷酸( 15 ︰ 85),检测波长238 nm。测得栀子苷、栀子苷元与小牛血清白蛋白、人血清白蛋白和大鼠血浆的蛋白结合率分别为(38.1±4.2)%和(63.4±1.2)%,(17.6±4.9)%和(81.5±6.2)%,以及(24.5±3.8)%和(94.6±1.0)%。结果表明栀子苷元与血浆蛋白的结合力高于栀子苷。

Abstract

An HPLC method was established for the determination of plasma protein binding rates of geniposide and genipin. A C18 column was used with the mobile phase of acetonitrile-0.05% phosphoric acid(15︰85) at the detection wavelength of 238 nm. The plasma protein binding rates of geniposide and genipin with BSA, HSA and rat plasma were (38.1±4.2)% and (63.4±1.2)%, (17.6±4.9)% and (81.5±6.2)%, (24.5±3.8)% and (94.6±1.0)%, respectively. The results showed that the binding capacity of genipin with the above plasma proteins was higher than that of geniposide.

关键词

栀子苷 / 栀子苷元 / 血浆蛋白结合率 / 高效液相色谱 / 测定

Key words

geniposide / genipin / plasma protein binding rate / HPLC / determination

引用本文

导出引用
丁 越1, 张 彤1*, 陶建生1, 李梦艺2, 蔡贞贞1. 栀子苷和栀子苷元血浆蛋白结合率的HPLC 法测定. 中国医药工业杂志. 2012, 43(10): 857-860
DING Yue1, ZHANG Tong1*, TAO Jian-Sheng1, LI Meng-Yi2, CAI Zhen-Zhen1. Determination of Plasma Protein Binding Rates of Geniposide and Genipin by HPLC. Chinese Journal of Pharmaceuticals. 2012, 43(10): 857-860

参考文献

[1] Ma T, Huang C, Zong G, et al. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis [J]. J Pharm Pharmacol, 2011, 63(4): 587-593.
[2] 方尚玲, 刘源才, 张庆华, 等. 栀子苷镇痛和抗炎作用的研究[J]. 时珍国医国药, 2008, 19(6): 1374-1376.
[3] 侯金才, 张摇鹏, 刘建勋, 等. 栀子苷对缺氧/ 复氧小胶质细胞TLR4 通路的影响[ J] . 中国药理学通报, 2011, 27(6): 769-773.
[4] Yamazaki M, Chiba K, Mohri T, et a1. Activation of the mitogen-activated protein kinase cascade through nitric oxide synthesis as a mechanism of neuritogenic effect of genipin in PC12h cells [J]. J Neurochem, 2001, 79(1): 45-54.
[5] Suzuki Y, Kondo K, Ikeda Y. Antithrombotic effect of geniposide and genipin in the mouse thrombosis model [J]. Planta Med, 2001, 67(9): 807-810.
[6] Pennacchio M, Syah YM, Ghisalberti EL, et al. Cardioactive compounds from Eremophila species[J]. J Ethnopharmacol, 1996, 53(1): 21-27.
[7] Kim BC, Kim HG, Lee SA, et al. Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway [J]. Biochem Pharmacol, 2005, 70(9): 1398-1407.
[8] Ding Y, Zhang T, Tao JS, et al. HPLC-MS/MS method to determine genipin in rat plasma after hydrolysis with sulfatase and its application to a pharmacokinetic study [J]. Biomed Chromatogr, 2012, 26(7): 816-825.
[9] 傅旭春, 柯 芳, 詹淑玉. 从分子极性表面积预测头孢菌素类药物的血浆蛋白结合率[J]. 浙江大学学报( 医学版), 2007, 36(4): 386-390.
[10] 曾烃泽主编. 生物药物分析[M]. 2 版, 北京: 中国医药科技出版社, 1998: 243.

基金

国家自然基金(81173561)、教育部新世纪人才计划(NCET-10-0944)、上海市教委重点学科(J50302)、上海市教委科研基金(2010JW21)

123

Accesses

0

Citation

Detail

段落导航
相关文章

/